Production Featured Articles
-
BD Innovation For Subcutaneous Delivery Of Large-Volume Complex Biologics
5/9/2024
Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.
-
Viral Vector Producer Cell Lines: Learning From mAbs
5/7/2024
Learn how applying bioprocessing knowledge from the production of mAbs can accelerate the development of viral vector cell lines and improve efficiency in gene therapy manufacturing.
-
Delivering On GLP-1 Demand: Combining Device And Supply Strategy
5/7/2024
Meeting the surge in demand for GLP-1 treatments requires robust and efficient delivery systems. Review how innovative solutions, including the Alina® pen injector platform and Aidaptus® auto-injector platform, offer customization, streamlined manufacturing, and compatibility with various drug formulations.
-
Nitrosamines: New WHO Guidance Provides Expanded Risk Assessment Considerations
5/6/2024
Nitrosamines are potential contaminants of drug products. Contamination can occur from synthesizing APIs and excipients, from leaching into the product from primary packaging, and more.
-
Quality Imperatives In Oral Solid Dosage Manufacturing: An Overview
5/2/2024
This article overviews the critical aspects of OSD manufacturing and the importance of understanding and implementing regulatory guidelines within the context of quality.
-
How To Choose The Right CDMO For Your Pharmaceutical Project- Part One: Will They Deliver?
4/17/2024
Choosing the right CDMO is crucial for the success of your pharmaceutical project. Learn how to strike the ideal balance between an organization's technical expertise, facilities, and efficiency.
-
Navigating OSD Formulation Development And Leveraging CDMO Partnership
4/17/2024
Collaborating with an experienced CDMO can provide the expertise and facilities needed to navigate oral solid dose formulation complexities and ensure compliance with regulatory frameworks.
-
Tips For Viral Vector Production
4/16/2024
Learn about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements.
-
What Is A Viral Vector?
4/16/2024
Review a novel adenovirus production process that offers scalable, single-use equipment-compatible solutions, reducing production time and cross-contamination risks.
-
Nucleic Acid Therapeutics And Environmental Impact
4/11/2024
Nucleic acid therapeutics offer exciting new avenues of treatment. Learn about the history of nucleic acid therapeutics and the environmental impact of manufacturing mRNA and oligonucleotides.